Latest news
Latigo Biotherapeutics, Clinical-Stage Developer of Selective Nav1.8 Non‑Opioid Pain Medicines for Acute and Chronic Pain, Files for Nasdaq Global Select Market IPO - TradingViewTradingView · Fri, 07 Aug 2026 20:39:00 GMTBlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - TradingViewTradingView · Fri, 07 Aug 2026 20:09:00 GMTZensitive, Fit-Out Work Provider In Hong Kong, Files For Nasdaq Capital Market IPO - TradingViewTradingView · Fri, 07 Aug 2026 16:47:02 GMTBending Spoons IPO: Mysterious owner of Vimeo, AOL, and Eventbrite files for stock market debut - Fast CompanyFast Company · Thu, 06 Aug 2026 07:00:00 GMTVimeo owner Bending Spoons files for IPO on Nasdaq - Investing.comInvesting.com · Thu, 06 Aug 2026 07:00:00 GMTCORRECTING and REPLACING Powerlaw Corp. (Nasdaq: PWRL) Announces Shield AI as Newest Holding & Files Updated Schedule of Investments - Business WireBusiness Wire · Tue, 04 Aug 2026 21:38:00 GMTLatigo Biotherapeutics files for Nasdaq IPO at up to $18 per share - Investing.comInvesting.com · Tue, 04 Aug 2026 15:02:55 GMTLatigo Biotherapeutics files for $256M-$288M Nasdaq IPO - scanx.tradescanx.trade · Mon, 03 Aug 2026 20:21:51 GMT